Concepedia

Michael Tanaka

MT

Statistics

Publications

13

Citations

2.4K

H-Index

13

Active since

1991

Affiliations

University of California, Davis(Current)

USC Norris Comprehensive Cancer Center

University of Illinois Chicago

BC Cancer Agency

UC Davis Comprehensive Cancer Center

Michael Tanaka is an author at University of California, Davis specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1991–2016

13

Publications

13

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Charles D. Blanke, Cathryn Rankin, George D. Demetri et al. · Journal of Clinical Oncology · 2008 · 1.1K citations

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Primo N. Lara, Roger Higdon, Nelson Lim et al. · Journal of Clinical Oncology · 2001 · 601 citations

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

Ramesh K. Ramanathan, Chandra P. Belani, D. A. Singh et al. · Cancer Chemotherapy and Pharmacology · 2009 · 286 citations

, , +9

Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144

Stephen R. Smalley, Jacqueline Benedetti, Stephen K. Williamson et al. · Journal of Clinical Oncology · 2006 · 166 citations · Full text

Premedication Strategy for Weekly Paclitaxel

Justin Quock, Gilland Dea, Michael Tanaka et al. · Cancer Investigation · 2002 · 44 citations

1–5 of 13